Group 1 - The core focus of Neuralink is on developing the Blindsight chip to assist visually impaired individuals, with plans to perform 10,000 surgeries annually by 2030, generating over $500 million in revenue [1] - Neuralink's strategy includes enhancing visual reconstruction through high-channel electrode stimulation of the visual cortex, aiming for basic black-and-white contour perception by 2026 [1] - The collaboration with the University of California, Santa Barbara, aims to address key scientific issues in the development of smart bionic eyes, integrating AI for functionalities like face recognition and outdoor navigation [1] Group 2 - The market potential for brain-machine interface (BMI) applications is significant, with McKinsey predicting the global medical application market could reach $40 billion by 2030 and $145 billion by 2040 [2] - The medical sector remains the primary focus for BMI commercialization, with over half of downstream application solution companies targeting healthcare [3] - Key beneficiaries of the accelerating BMI industry include companies like Rock Mountain Technology, Zhongke Information, and others, as policy and technology converge [3]